Canada Wound Care Management Medical Equipment Industry Report

Summary

This report is an essential source for in-depth information and data relating to Canada wound care management medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management in Canada

Scope

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

• 1 Table of Contents
  • 1.1 List of Tables
  • 1.2 List of Figures
• 2 Introduction
  • 2.1 What Is This Report About?
  • 2.2 Definitions
    • 2.2.1 Wound Care Management
      • 2.2.1.1 Traditional Wound Management
      • 2.2.1.2 Advanced Wound Management
      • 2.2.1.3 Wound Closure Devices
      • 2.2.1.4 Ostomy
      • 2.2.1.5 Compression Therapy
• 3 Healthcare Sector Review
  • 3.1 Healthcare Expenditure
  • 3.2 Healthcare Infrastructure
  • 3.3 Healthcare Policy
• 4 Wound Care Management in Canada
  • 4.1 Wound Care Management Overall Revenues (2000-2012)
  • 4.2 Wound Care Management Overall Volume (2000-2012)
  • 4.3 Wound Care Management Overall Company Shares (2005-2006)
• 5 Wound Closure Devices in Canada
  • 5.1 Wound Closure Devices Overall Revenues (2000-2012)
    • 5.1.1 Skin Closure Devices Overall Revenues (2000-2012)
    • 5.1.2 Hemostats Overall Revenues (2000-2012)
    • 5.1.3 Tissue Sealants Overall Revenues (2000-2012)
  • 5.2 Wound Closure Devices Overall Volume (2000-2012)
    • 5.2.1 Skin Closure Devices Overall Volume (2000-2012)
    • 5.2.2 Tissue Sealants Overall Volume (2000-2012)
    • 5.2.3 Hemostats Overall Volume (2000-2012)
  • 5.3 Wound Closure Devices Average Price (2000-2012)
    • 5.3.1 Hemostats Average Price (2000-2012)
    • 5.3.2 Tissue Sealants Average Price (2000-2012)
    • 5.3.3 Skin Closure Devices Average Price (2000-2012)
  • 5.4 Wound Closure Devices Distribution Share (2000-2012)
  • 5.5 Wound Closure Devices Company Share (2000-2012)
• 6 Ostomy in Canada
  • 6.1 Ostomy Overall Revenue (2000-2012)
  • 6.2 Ostomy Overall Volume (2000-2012)
  • 6.3 Ostomy Average Price (2000-2012)
  • 6.4 Ostomy Distribution Share (2005-2006)
  • 6.5 Ostomy Company Share (2005-2006)
• 7 Advanced Wound Management in Canada
  • 7.1 Advanced Wound Management Overall Revenue (2000-2012)
  • 7.2 Advanced Wound Management Overall Volume (2000-2012)
  • 7.3 Advanced Wound Management Average Price (2000-2012)
  • 7.4 Advanced Wound Management Distribution Share (2005-2006)
  • 7.5 Advanced Wound Management Company Share (2005-2006)
• 8 Traditional Wound Management in Canada
  • 8.1 Traditional Wound Management Overall Revenue (2000-2012)
  • 8.2 Traditional Wound Management Overall Volume (2000-2012)
  • 8.3 Traditional Wound Management Average Price (2000-2012)
  • 8.4 Traditional Wound Management Distribution Share (2000-2012)
  • 8.5 Traditional Wound Management Company Share (2000-2012)
• 9 Compression Therapy in Canada
  • 9.1 Compression Therapy Overall Revenue (2000-2012)
  • 9.2 Compression Therapy Overall Volume (2000-2012)
  • 9.3 Compression Therapy Average Price (2000-2012)
  • 9.4 Compression Therapy Distribution Share (2000-2012)
  • 9.5 Compression Therapy Company Share (2000-2012)
• 10 Baxter International Company Profile
  • 10.1 Company Overview
  • 10.2 Business Overview
    • 10.2.1 BioScience
    • 10.2.2 Medication Delivery
    • 10.2.3 Renal
    • 10.2.4 Products
    • 10.2.5 History
  • 10.3 Value Chain Analysis
    • 10.3.1 Manufacturing
    • 10.3.2 Product Development
    • 10.3.3 Sales and Marketing
  • 10.4 SWOT Analysis
    • 10.4.1 Baxter International Inc. Strengths
    • 10.4.2 Baxter International Inc. Weaknesses
    • 10.4.3 Baxter International Inc. Opportunities
    • 10.4.4 Baxter International Inc. Threats
  • 10.5 Financial and Operational Review
  • 10.6 Locations And Subsidiaries
  • 10.7 Financial Deals Landscape
    • 10.7.1 Baiyunshan And Baxter Form A Joint Venture In China
    • 10.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration
    • 10.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital
    • 10.7.4 B. Braun Acquires Renal Therapy Business Of Baxter
    • 10.7.5 Innovata signs a license agreement with Baxter International
    • 10.7.6 Kuros Biosurgery Signs An Agreement With Baxter International
    • 10.7.7 Gambro Signs An Agreement With Baxter
    • 10.7.8 Baxter Healthcare And Gambro Enter Into An Agreement
    • 10.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System
    • 10.7.10 Baxter International And Kaketsuken Enter Into Agreement
    • 10.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful
  • 10.8 Recent Developments
    • 10.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007
    • 10.8.2 Dec 18, 2007: Baxter Elects CFO
    • 10.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend
    • 10.8.4 Aug 01, 2007: Baxter Elects New Board Director
    • 10.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend
    • 10.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization
    • 10.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend
    • 10.8.8 Nov 28, 2006: Baxter Announces Annual Dividend
    • 10.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America
  • 10.9 Baxter International Inc. Pipeline Products
    • 10.9.1 Next-Generation Home Hemodialysis Machine
• 11 Covidien Ltd./Tyco Healthcare Company Profile
  • 11.1 Company Overview
  • 11.2 Business Overview
    • 11.2.1 Imaging Solutions
    • 11.2.2 Medical Devices
    • 11.2.3 Medical Supplies
    • 11.2.4 Pharmaceutical Products
    • 11.2.5 Retail Products
    • 11.2.6 Products
    • 11.2.7 History
  • 11.3 Value Chain Analysis
    • 11.3.1 Manufacturing
    • 11.3.2 Product Development
    • 11.3.3 Sales and Marketing
  • 11.4 SWOT Analysis
    • 11.4.1 Covidien Ltd./Tyco Healthcare Strengths
    • 11.4.2 Covidien Ltd./Tyco Healthcare Weaknesses
    • 11.4.3 Covidien Ltd./Tyco Healthcare Opportunities
    • 11.4.4 Covidien Ltd./Tyco Healthcare Threats
  • 11.5 Financial and Operational Review
    • 11.5.1 Financial Statements
    • 11.5.2 Financial Ratios
  • 11.6 Locations And Subsidiaries
  • 11.7 Financial Deals Landscape
    • 11.7.1 Covidien Signs An Agreement With Allergan
    • 11.7.2 Covidien Acquires Scandius Biomedical
    • 11.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million
    • 11.7.4 Covidien And BioSynthema Enter Into Licensing Agreement
    • 11.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien
    • 11.7.6 Covidien To Sell European Incontinence Business
    • 11.7.7 Covidien To Acquire Tissue Science Laboratories
  • 11.8 Recent Developments
    • 11.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007
    • 11.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend
    • 11.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case
    • 11.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results
    • 11.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend
    • 11.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results
    • 11.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results
    • 11.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent
    • 11.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend
    • 11.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results
  • 11.9 Covidien Ltd./Tyco Healthcare Pipeline Products
    • 11.9.1 PleuraSeal Lung Sealant System
      • Product Overview
      • Product Description
      • Product Status
      • Product Milestone
    • 11.9.2 Sandman Intro CPAP Device
      • Product Overview
      • Product Description
      • Product Status
      • Product Milestone
• 12 3M Company Profile
  • 12.1 Company Overview
  • 12.2 Business Overview
    • 12.2.1 Consumer and Office
    • 12.2.2 Display and Graphics
    • 12.2.3 Electro and Communications
    • 12.2.4 Health Care
    • 12.2.5 Industrial and Transportation
    • 12.2.6 Safety, Security and Protection Services
    • 12.2.7 Products
  • 12.3 Value Chain Analysis
    • 12.3.1 Manufacturing
    • 12.3.2 Product Development
    • 12.3.3 Sales and Marketing
  • 12.4 SWOT Analysis
    • 12.4.1 3M Company Strengths
• 3M Company Weaknesses
• 3M Company Opportunities
• 3M Company Threats
  • 12.5 Financial and Operational Review
  • 12.6 Locations And Subsidiaries
  • 12.7 Financial Deals Landscape
    • 12.7.1 3M Canada Acquires Les Entreprises Solumed
    • 12.7.2 3M Acquires Bondo
    • 12.7.3 3M Acquires Lingualcare
    • 12.7.4 3M Acquires Abzil Industria E Comercio
    • 12.7.5 3M Acquires Neo Plast
    • 12.7.6 3M Acquires Assets Of DMS Chile
    • 12.7.7 3M Acquires Business Of Innovative Paper Technologies
    • 12.7.8 3M Acquires Powell
    • 12.7.9 Gen-Probe Signs An Agreement With 3M Company
    • 12.7.10 3M Acquires Acolyte Biomedica
    • 12.7.11 3M Acquires Sealed Air Corp.'S Interest In Polymask Corp
    • 12.7.12 3M Sells Its Pharmaceutical Business To Meda AB
    • 12.7.13 3M Acquires SoftMed Systems
    • 12.7.14 3M Sells its Pharmaceuticals Business to Graceway
    • 12.7.15 Gen-Probe Signs An Agreement With 3M
    • 12.7.16 3M Sells its Pharmaceutical Operations in the Asia Pacific Region to Ironbridge Capital and Archer Capital
    • 12.7.17 3M Acquires Biotrace International
    • 12.7.18 Ekahau Secures $16 Million In Additional Funding
    • 12.7.19 3M Acquires Brontes Technologies
    • 12.7.20 3M acquires Nylonge Corp
    • 12.7.21 3M Signs An Agreement With ClozeX Medical
    • 12.7.22 3M Acquires OMNII Oral Pharmaceuticals
    • 12.7.23 3M Sells Pharmaceutical Operations In The United States To Graceway
    • 12.7.24 3M Sells Pharmaceutical Business In Europe To Meda AB
    • 12.7.25 3M Sells Pharmaceutical Operations In The Asia Pacific To Ironbridge and Archer Capital
    • 12.7.26 3M Acquires Accuspray Application Technologies Inc
    • 12.7.27 3M to acquire Rochford Thompson Equipment
    • 12.7.28 3M To Acquire Aearo Technologies From Permira
    • 12.7.29 Permira To Sell Aearo Technologies To 3M
  • 12.8 Recent Developments
    • 12.8.1 Mar 31, 2008: HighJump Software Introduces Survey Management Solution for Direct Store Delivery Businesses
    • 12.8.2 Mar 24, 2008: Brazil's Companhia de Transmissao de Energia Eletrica Paulista Chooses 3M ACCR for Upgrade of Line Over Parana River in Sao Paulo State
    • 12.8.3 Mar 19, 2008: 3M to Headquarter Optical Systems Business in Asia
    • 12.8.4 Mar 19, 2008: 3M To Headquarter Optical Systems Business In North Asia
    • 12.8.5 Feb 11, 2008: 3M Increases Dividend for the 50th Straight Year
    • 12.8.6 Nov 12, 2007: 3M Declares Quarterly Dividend
    • 12.8.7 Oct 24, 2007: 3M And Sanyo Settle Suit On Lithium Ion Battery
    • 12.8.8 Aug 13, 2007: 3M Declares Quarterly Dividend
    • 12.8.9 May 08, 2007: 3M Declares Quarterly Dividend
    • 12.8.10 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests
• 13 Ethicon, Inc. Company Profile
  • 13.1 Company Overview
  • 13.2 Business Overview
    • 13.2.1 Products
  • 13.3 Locations And Subsidiaries
  • 13.4 Financial Deals Landscape
    • 13.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON
    • 13.4.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON
    • 13.4.3 ETHICON Acquires Vascular Control Systems
    • 13.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON
• 14 Smith & Nephew Plc Company Profile
  • 14.1 Company Overview
  • 14.2 Business Overview
    • 14.2.1 Advanced Wound Management
    • 14.2.2 Endoscopy
    • 14.2.3 Reconstruction
    • 14.2.4 Trauma and Clinical Therapies
    • 14.2.5 Products
    • 14.2.6 History
  • 14.3 Value Chain Analysis
    • 14.3.1 Manufacturing
    • 14.3.2 Product Development
    • 14.3.3 Sales and Marketing
  • 14.4 SWOT Analysis
    • 14.4.1 Smith & Nephew Plc Strengths
    • 14.4.2 Smith & Nephew Plc Weaknesses
    • 14.4.3 Smith & Nephew Plc Opportunities
    • 14.4.4 Smith & Nephew Plc Threats
  • 14.5 Financial and Operational Review
  • 14.6 Locations And Subsidiaries
  • 14.7 Other Locations & Subsidiaries
  • 14.8 Financial Deals Landscape
    • 14.8.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein
    • 14.8.2 Smith & Nephew Signs An Agreement With Universal Hospital Services
    • 14.8.3 Smith & Nephew Acquires Plus Orthopedics Holding
    • 14.8.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement
    • 14.8.5 Smith & Nephew Acquires BlueSky Medical Group
    • 14.8.6 Smith & Nephew Enters Into An Agreement With Covalon
    • 14.8.7 Smith & Nephew Signs An Agreement With UDL Laboratories
    • 14.8.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew
    • 14.8.9 Smith & Nephew Acquires Osteobiologics
    • 14.8.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement
    • 14.8.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity
    • 14.8.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew
    • 14.8.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies
    • 14.8.14 Smith & Nephew Signs An Agreement With ORTHOsoft
    • 14.8.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement
    • 14.8.16 Smith & Nephew Acquires VERSAJET From HydroCision
    • 14.8.17 Smith & Nephew Terminates Acquisition Of Biomet
  • 14.9 Recent Developments
    • 14.9.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend
    • 14.9.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results
    • 14.9.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America's Hip Generation
    • 14.9.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM
    • 14.9.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation Nails
    • 14.9.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend
    • 14.9.7 May 03, 2007: Smith & Nephew Appoints New CEO
  • 14.10 Smith & Nephew Plc Pipeline Products
    • 14.10.1 R3 Modular resurfacing Acetabular system
    • 14.10.2 R3 Ceramic-on-ceramic Acetabular System
• 15 Regulation System
  • 15.1 Medical Equipment Approval Process
    • 15.1.1 Classification
    • 15.1.2 Conformity Assessment
      • 15.1.2.1 Class II
      • 15.1.2.2 Class III
      • 15.1.2.3 Class IV
    • 15.1.3 License Fee
    • 15.1.4 License Application Processing Duration
  • 15.2 Labeling and Packaging
  • 15.3 Post-Market Surveillance
• 16 Pricing and Reimbursement
• 17 Distribution Structure
  • 17.1 Distribution Structure
• 18 APPENDIX
  • 18.1 Global Markets Direct Research Methodology
  • 18.2 Coverage
  • 18.3 Secondary Research
  • 18.4 Primary Research
  • 18.5 Models
  • 18.6 Forecasts
  • 18.7 Expert Panels
  • 18.8 Currency Conversion
  • 18.9 Contact Us
  • 18.10 Disclaimer
• `
• List of Tables
  • Table 1: Number of Physicians by Province in Canada, 2001 and 2005
  • Table 2: Hospital Wards by Specialty in Canada, 2003-2007
  • Table 3: Doctors by Specialty in Canada, 2003-2007
  • Table 4: Wound Care Management, Canada, Overall Revenues ($ mn), 2000-2012
  • Table 5: Wound Care Management, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 6: Wound Care Management, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 7: Wound Care Management, Canada, Category Revenues ($ mn), 2000-2012
  • Table 8: Wound Care Management, Canada, Category Revenues ($ mn), Historic, 2000-2007
  • Table 9: Wound Care Management, Canada, Category Revenues ($ mn), Forecast, 2007-2012
  • Table 10: Wound Care Management, Canada, Category Volume (Units), 2000-2012
  • Table 11: Wound Care Management, Canada, Category Volume (Units), Historic, 2000-2007
  • Table 12: Wound Care Management, Canada, Category Volume (Units), Forecast, 2007-2012
  • Table 13: Wound Care Management, Canada, Company Share by Revenue ($ mn), 2005-2006
  • Table 14: Wound Closure Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 15: Wound Closure Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 16: Wound Closure Devices Canada, Revenue by Segment ($ mn), Historic, 2000-2007
  • Table 17: Wound Closure Devices, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012
  • Table 18: Skin Closure Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 19: Skin Closure Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 20: Hemostats, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 21: Hemostats, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 22: Tissue Sealants, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 23: Tissue Sealants, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 24: Wound Closure Devices, Canada, Overall Volume (Units), Historic, 2000-2007
  • Table 25: Wound Closure Devices, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Table 26: Skin Closure Devices, Canada, Overall Volume (Units), Historic, 2000-2007
  • Table 27: Skin Closure Devices, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Table 28: Tissue Sealants, Canada, Overall Volume (Units), Historic, 2000-2007
  • Table 29: Tissue Sealants, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Table 30: Hemostats, Canada, Overall Volume (Units), Historic, 2000-2007
  • Table 31: Hemostats, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Table 32: Hemostats, Canada, Average Price ($), Historic, 2000-2007
  • Table 33: Hemostats, Canada, Average Price ($), Forecast, 2007-2012
  • Table 34: Tissue Sealants, Canada, Average Price ($), Historic, 2000-2007
  • Table 35: Tissue Sealants, Canada, Average Price ($), Forecast, 2007-2012
  • Table 36: Skin Closure Devices, Canada, Average Price ($), Historic, 2000-2007
  • Table 37: Skin Closure Devices, Canada, Average Price ($), Forecast, 2007-2012
  • Table 38: Wound Closure Devices Canada, Distribution Share by Revenue ($ mn), 2005-2006
  • Table 39: Wound Closure Devices, Canada, Company Share by Revenue ($ mn), 2005-2006
  • Table 40: Ostomy, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 41: Ostomy, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 42: Ostomy, Canada, Overall Volume (Units), Historic, 2000-2007
  • Table 43: Ostomy, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Table 44: Ostomy, Canada, Average Price ($), Historic, 2000-2007
  • Table 45: Ostomy, Canada, Average Price ($), Forecast, 2007-2012
  • Table 46: Ostomy, Canada, Distribution Share by Revenue ($ mn), 2005-2006
  • Table 47: Ostomy, Canada, Company Share by Revenue ($ mn), 2005-2006
  • Table 48: Advanced Wound Management, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 49: Advanced Wound Management, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 50: Advanced Wound Management, Canada, Overall Volume (Units), Historic, 2000-2007
  • Table 51: Advanced Wound Management, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Table 52: Advanced Wound Management, Canada, Average Price ($), Historic, 2000-2007
  • Table 53: Advanced Wound Management, Canada, Average Price ($), Forecast, 2007-2012
  • Table 54: Advanced Wound Management, Canada, Distribution Share by Revenue ($ mn), 2005-2006
  • Table 55: Advanced Wound Management, Canada, Company Share by Revenue ($ mn), 2005-2006
  • Table 56: Traditional Wound Management, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 57: Traditional Wound Management, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 58: Traditional Wound Management, Canada, Overall Volume (Units), Historic, 2000-2007
  • Table 59: Traditional Wound Management, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Table 60: Traditional Wound Management, Canada, Average Price ($), Historic, 2000-2007
  • Table 61: Traditional Wound Management, Canada, Average Price ($), Forecast, 2007-2012
  • Table 62: Traditional Wound Management, Canada, Distribution Share by Revenue ($ mn), 2005-2006
  • Table 63: Traditional Wound Management, Canada, Company Share by Revenue ($ mn), 2005-2006
  • Table 64: Compression Therapy, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 65: Compression Therapy, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 66: Compression Therapy, Canada, Overall Volume (Units), Historic, 2000-2007
  • Table 67: Compression Therapy, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Table 68: Compression Therapy, Canada, Average Price ($), Historic, 2000-2007
  • Table 69: Compression Therapy, Canada, Average Price ($), Forecast, 2007-2012
  • Table 70: Compression Therapy, Canada, Distribution Share by Revenue ($ mn), 2005-2006
  • Table 71: Compression Therapy, Canada, Company Share by Revenue ($ mn), 2005-2006
  • Table 72: Baxter International Inc., SWOT Analysis, 2006
  • Table 73: Baxter International Inc., Financial Statements, USD Million, 2002-2006
  • Table 74: Baxter International Inc., Financial Ratios, USD Million, 2002-2006
  • Table 75: Baxter International Inc., Other Locations
  • Table 76: Baxter International Inc., Subsidiaries
  • Table 77: Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007
  • Table 78: Covidien Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007
  • Table 79: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD Million, 2003-2007
  • Table 80: Covidien Ltd./Tyco Healthcare, Other Locations
  • Table 81: Covidien Ltd./Tyco Healthcare, Subsidiaries
  • Table 82: 3M Company, SWOT Analysis, 2006
  • Table 83: 3M Company, Financial Statements, USD Million, 2002-2006
  • Table 84: 3M Company, Financial and Operational Overview, USD Million, 2002-2006
  • Table 85: 3M Company, Subsidiaries
  • Table 86: Ethicon, Inc., Other Locations
  • Table 87: Ethicon, Inc., Subsidiaries
  • Table 88: Smith & Nephew Plc, SWOT Analysis, 2006
  • Table 89: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006
  • Table 90: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006
  • Table 91: Smith & Nephew Plc, Other Locations
  • Table 92: Medical Equipment Classification in Canada, 2007
  • Table 93: Medical Equipment Licensing Fee in Canada, 2007
  • Table 94: Medical Equipment License Processing Duration in Canada, 2007
  • Table 95: Currency Conversion from USD to Local Currency at 2007 Constant Rate
• List of Figures
  • Figure 1: Healthcare Financing in Canada, 2004
  • Figure 2: Healthcare Expenditure in Canada, 2000 - 2006
  • Figure 3: Wound Care Management, Canada, Overall Revenues ($ mn), 2000-2012
  • Figure 4: Wound Care Management, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 5: Wound Care Management, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 6: Wound Care Management, Canada, Category Revenues ($ mn), 2000-2012
  • Figure 7: Wound Care Management, Canada, Category Revenues ($ mn), Historic, 2000-2007
  • Figure 8: Wound Care Management, Canada, Category Revenues ($ mn), Forecast, 2007-2012
  • Figure 9: Wound Care Management, Canada, Category Volume (Units), 2000-2012
  • Figure 10: Wound Care Management, Canada, Category Volume (Units), Historic, 2000-2007
  • Figure 11: Wound Care Management, Canada, Category Volume (Units), Forecast, 2007-2012
  • Figure 12: Wound Care Management, Canada, Company Share (%), 2006
  • Figure 13: Wound Closure Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 14: Wound Closure Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 15: Wound Closure Devices, Canada, Revenue by Segment ($ mn), Historic, 2000-2007
  • Figure 16: Wound Closure Devices, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012
  • Figure 17: Skin Closure Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 18: Skin Closure Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 19: Hemostats, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 20: Hemostats, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 21: Tissue Sealants, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 22: Tissue Sealants, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 23: Wound Closure Devices, Canada, Overall Volume (Units), Historic, 2000-2007
  • Figure 24: Wound Closure Devices, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Figure 25: Skin Closure Devices, Canada, Overall Volume (Units), Historic, 2000-2007
  • Figure 26: Skin Closure Devices, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Figure 27: Tissue Sealants, Canada, Overall Volume (Units), Historic, 2000-2007
  • Figure 28: Tissue Sealants, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Figure 29: Hemostats, Canada, Overall Volume (Units), Historic, 2000-2007
  • Figure 30: Hemostats, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Figure 31: Hemostats, Canada, Average Price ($), Historic, 2000-2007
  • Figure 32: Hemostats, Canada, Average Price ($), Forecast, 2007-2012
  • Figure 33: Tissue Sealants, Canada, Average Price ($), Historic, 2000-2007
  • Figure 34: Tissue Sealants, Canada, Average Price ($), Forecast, 2007-2012
  • Figure 35: Skin Closure Devices, Canada, Average Price ($), Historic, 2000-2007
  • Figure 36: Skin Closure Devices, Canada, Average Price ($), Forecast, 2007-2012
  • Figure 37: Wound Closure Devices, Canada, Distribution Share (%), 2006
  • Figure 38: Wound Closure Devices, Canada, Company Share (%), 2006
  • Figure 39: Ostomy, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 40: Ostomy, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 41: Ostomy, Canada, Overall Volume (Units), Historic, 2000-2007
  • Figure 42: Ostomy, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Figure 43: Ostomy, Canada, Average Price ($), Historic, 2000-2007
  • Figure 44: Ostomy, Canada, Average Price ($), Forecast, 2007-2012
  • Figure 45: Ostomy, Canada, Company Share (%), 2006
  • Figure 46: Advanced Wound Management, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 47: Advanced Wound Management, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 48: Advanced Wound Management, Canada, Overall Volume (Units), Historic, 2000-2007
  • Figure 49: Advanced Wound Management, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Figure 50: Advanced Wound Management, Canada, Average Price ($), Historic, 2000-2007
  • Figure 51: Advanced Wound Management, Canada, Average Price ($), Forecast, 2007-2012
  • Figure 52: Advanced Wound Management, Canada, Distribution Share (%), 2006
  • Figure 53: Advanced Wound Management, Canada, Company Share (%), 2006
  • Figure 54: Traditional Wound Management, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 55: Traditional Wound Management, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 56: Traditional Wound Management, Canada, Overall Volume (Units), Historic, 2000-2007
  • Figure 57: Traditional Wound Management, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Figure 58: Traditional Wound Management, Canada, Average Price ($), Historic, 2000-2007
  • Figure 59: Traditional Wound Management, Canada, Average Price ($), Forecast, 2007-2012
  • Figure 60: Traditional Wound Management, Canada, Distribution Share (%), 2006
  • Figure 61: Traditional Wound Management, Canada, Company Share (%), 2006
  • Figure 62: Compression Therapy, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 63: Compression Therapy, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 64: Compression Therapy, Canada, Overall Volume (Units), Historic, 2000-2007
  • Figure 65: Compression Therapy, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Figure 66: Compression Therapy, Canada, Average Price ($), Historic, 2000-2007
  • Figure 67: Compression Therapy, Canada, Average Price ($), Forecast, 2007-2012
  • Figure 68: Compression Therapy, Canada, Distribution Share (%), 2006
  • Figure 69: compression therapy, Canada, Company Share (%), 2006
  • Figure 70: Baxter International Inc., Value Chain Analysis
  • Figure 71: Covidien Ltd./Tyco Healthcare, Value Chain Analysis
  • Figure 72: 3M Company, Value Chain Analysis
  • Figure 73: Smith & Nephew Plc, Value Chain Analysis
  • Figure 74: Global Markets Direct Methodology